类似PA1b的可以缓解由葡萄糖毒性引起的线粒体功能障碍,通过与β细胞中的VDAC1相互作用来缓解
Huizhong Huang1, Xinyu Zeng1, Liying Zhang1
1Sino-German Biomedical Center, Hubei Provincial Key Laboratory of Industrial Microbiology, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), Key Laboratory of Fermentation Engineering (Ministry of Education), National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Hubei University of Technology, 430068 Wuhan, Hubei, China. yaochenguang@hbut.edu.cn.
Food & function
|March 4, 2025
概括
来自大豆的PA1b类可以通过与VDAC1,一种关键的线粒体蛋白相互作用来保护胰腺β细胞. 这种相互作用恢复了线粒体功能和胰岛素分泌,为2型糖尿病提供了新的治疗策略.
科学领域:
- 植物生物化学 植物生物化学
- 分子生物学分子生物学
- 内分泌学 在内分泌学.
背景情况:
- 来自Fabaceae种子的PA1b类显示出低血糖和β细胞保护作用.
- 这些在小岛β细胞中的精确分子标和机制尚未完全理解.
研究的目的:
- 研究大豆种子中PA1b类的分布.
- 在β细胞中识别PA1b类的直接分子标.
- 阐明这些可以保护β细胞免受高葡萄糖毒性的机制.
主要方法:
- 在大豆中的酸局部化分析.
- 使用结合能量的计算,在体中识别-标相互作用.
- 分子动力学模拟来分析-VDAC1复合体的稳定性.
- 在β细胞中评估线粒体功能 (ROS,ATP,膜潜力) 和胰岛素分泌.
主要成果:
- 类似PA1b的主要存在于大豆花皮中.
- 确定了PA1b类和电压依赖离子通道 (VDACs) 之间的直接相互作用,具有很高的结合亲和力.
- 分子动力学模拟证实了稳定的-VDAC1复合物的形成.
- 维格利 (VG),一种类似PA1b的,通过与VDAC1.1相互作用,在高葡萄糖下保护β细胞线粒体功能和胰岛素分泌.
结论:
- 类似PA1b的,特别是vglycin,在胰腺β细胞中直接与VDAC1相互作用.
- 这种相互作用对于维持线粒体功能和胰岛素分泌在葡萄糖毒性下至关重要.
- 这些发现为使用PA1b类作为2型糖尿病治疗策略提供了理论依据.
相关概念视频
Insulin Secretory Vesicles
4.8K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.8K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.0K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.0K
Glucagon-like Receptor Agonists
290
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
290
Electron Transport Chain: Complex I and II
10.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
10.1K


